Tex Heart Inst J. 2006; 33(1): 35–39.

Effect of Myocardial Reperfusion on the Release of Nitric Oxide after Regional Ischemia
An Experimental Model of Beating-Heart Surgery

Koki Nakamura, MD, Sharif Al-Ruzzeh, PhD, FRCS, Caroline Gray, PhD, Magdi Yacoub, FRCS, and Mohamed Amrani, PhD, FRCS

The National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, University of London, Harefield Hospital, Middlesex, United Kingdom

Abstract

Off-pump coronary artery bypass surgery is increasing in popularity worldwide. However, very little is known about the effect of regional myocardial ischemia-reperfusion on nitric oxide release.

In an animal model mimicking off-pump bypass, male Sprague-Dawley rats (350 --450 g) were mechanically ventilated under general anesthesia. After left lateral thoracotomy, the animals underwent occlusion of either the left anterior descending artery (for 3, 5, 7.5, 10, 12.5, 15, or 20 minutes) or the circumflex artery (for 5, 10, or 15 minutes). Twenty-four hours after reperfusion, heart tissue was stained for determination of the area at risk and the infarcted area. Blood samples obtained before ischemia, 10 minutes after reperfusion, and 24 hours after reperfusion were analyzed for plasma concentrations of nitric oxide.

After occlusion of the left anterior descending artery, the size of the infarcted area increased dramatically as the duration of occlusion increased, and was significantly larger after 12.5, 15, or 20 minutes of occlusion than after 3 minutes. After occlusion of the circumflex artery, the size of the infarcted area increased steadily and was significantly larger after 15 minutes of occlusion than after 5 minutes. There was no significant correlation between the duration of coronary occlusion and the plasma concentration of nitric oxide: 10 minutes after reperfusion, this concentration was significantly lower than that before ischemia, but it was twice the baseline level 24 hours after reperfusion. We concluded that the duration of regional ischemia did not affect the plasma concentration of nitric oxide in the systemic circulation.

Key words:: Animal model, coronary artery bypass, off-pump, coronary artery occlusion, temporary, myocardial ischemia, regional reversible, nitric oxide, rats, Sprague-Dawley, reperfusion injury

Since its revival during the past decade, off-pump coronary artery bypass surgery (OPCAB) has been increasing in popularity worldwide.1 Growing evidence regarding the hazards of using cardiopulmonary bypass (CPB) for multivessel coronary artery bypass grafting has prompted many cardiac surgeons in the United Kingdom to convert to OPCAB.2 However, very little is known about the correlation between nitric oxide (NO) release and regional ischemia --reperfusion.

We and others3 --5 have shown that endothelial dysfunction is common after ischemia --reperfusion injury and that postischemic impairment of the endothelium results from a reduction in the release of NO. Nitric oxide has numerous beneficial effects, including vasodilatory properties, an inhibitory action on platelet aggregation, and antioxidant effects.6 --12 Consequently, interventions aimed at reversing the impairment of NO synthesis could have important implications for cardiac function. However, the relationship between the ischemic period and the release of NO has not been completely ascertained, nor has the time course of NO release before and after ischemia --reperfusion. Therefore, we performed this study to investigate the effect of temporary coronary artery occlusion on the plasma concentration of NO and its changes over time.

Materials and Methods

Animals
Male Sprague-Dawley rats (350 --450 g) were used in all experiments. In all studies, animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH publication 85 --23, revised 1996).

Coronary Artery Occlusion
Rats were anesthetized with 50 mg/kg of sodium pentobarbital administered intraperitoneally. Rats underwent oral intubation with an 18-G soft venous can-nula and artificial ventilation with room air. During the experiments, the room temperature was maintained at 23 to 25[deg]C. In addition, a heating pad was placed beneath the animals to maintain a body temperature of 36.0 to 37.0[deg]C as determined by rectal temperature probe. A left lateral thoracotomy was performed at the level of the 4th or 5th intercostal space. The pericardium was opened, and the heart was exposed.

A 6-0 Prolene stitch was placed around the left anterior descending coronary artery (LAD), 2 mm distal to the left atrial appendage and around the circumflex artery (Cx), beneath the left atrial appendage along the atrioventricular groove. A short length of polyethylene tubing was placed over the suture as an occluder. The suture was tightened and clamped to produce coronary occlusion and was released to produce reperfusion. The LAD was occluded for 3, 5, 7.5, 10, 12.5, 15, or 20 minutes; the Cx was occluded for 5, 10, or 15 minutes. Reperfusion followed. Approximately 10 minutes later, the chest was closed, and the rats were allowed to awake spontaneously (1 -- 2 hours later). Control rats underwent thoracotomy followed by closure of the chest without occlusion of a coronary artery.

Myocardial Tissue Analysis
Twenty-four hours after reperfusion, the rats were again anesthetized in the manner described above and were intubated via tracheostomy. The chest was opened while the animals were artificially ventilated with room air. The coronary artery was re-occluded with the stitch that had been placed previously. The area at risk (AR) was stained with Evans blue dye (2 mL of 2% w/v) injected via the femoral vein. (The properties of Evans blue dye are such that the dye solution stains the perfused myocardium, but the occluded nonperfused myocardium remains uncolored.)

The heart was excised, the atrial and right ventricular walls were removed, and the left ventricle (LV) was cut into 4 or 5 horizontal slices. The AR, which included infarcted and ischemic myocardium, was separated from the nonischemic myocardium by following the line of demarcation between the blue-stained and the unstained (pink-to-red) tissue. So that ischemic and infarcted tissue could be differentiated, the AR was incubated in 0.1% nitro-blue tetrazolium (NBT) in a phosphate buffer (pH 7.4) at 37[deg]C for 15 minutes. (The NBT dye forms a blue formazan complex in the presence of coenzymes and dehydrogenases.) The infarcted myocardium was then separated from the ischemic myocardium that did not reach the degree of necrosis. The 3 portions of the LV myocardium (nonischemic, ischemic, and infarcted) were weighed: AR was the sum of the ischemic and infarcted areas (IF). The following percentages were calculated and the results analyzed: the portion of the left ventricle that was ischemic or infarcted (AR/LV), and the portion of AR that was infarcted (IF/AR).

Analysis of the Plasma Concentrations of Nitric Oxide
The plasma concentrations of NO were analyzed using 0.6-mL blood samples collected before thoracotomy and ischemia, 10 minutes after reperfusion, and 24 hours after reperfusion. The samples were centrifuged, and the plasma was stored at [minus sign]70[deg]C until the analyses were performed. Total NO production was determined with chemiluminescence by an NO analyzer (NOA 270, Sievers Instruments, Inc.; Boulder, Colo) to assay the amount of nitrite (the NO breakdown product) that was present, as previously described.3 Levels of NO were expressed in mol/L (M). Nitrite is measured as an index of total NO production, because NO2[minus sign] is the principal oxidation product in an aqueous solution devoid of any biological contaminants.

Statistical Analysis
All values are expressed as mean [plus minus] SEM. The 2 groups (LAD and Cx occlusion) were compared by using Student's t-test after confirmation that the data were normally distributed. Paired t-tests were used for time-course studies of NO levels. The relationship between the plasma NO level and the duration of coronary artery occlusion was analyzed by use of Spearman's rank correlation test. For multiple comparisons, 1-way analysis of variance (ANOVA) was performed, followed by Fisher's post hoc test to determine which relationships were statistically significant. A P-value of less than 0.05 was considered statistically significant.

Results

Sixty-nine rats were used for the study: 40 in the LAD group, 25 in the Cx group, and 4 as a control group (no occlusion). Forty-six rats (27 in the LAD group, 16 in the Cx group, and 3 in the control group) survived for 24 hours after reperfusion. The survival rate for the LAD group was 67.5%, and that for the Cx group was 64.0% (difference not statistically significant). Among the surviving animals, staining failed in 6 rats, and occlusion was not properly performed for 3 rats (as confirmed by staining). Consequently, the final analysis included 37 rats: 23 in the LAD group, 11 in the Cx group, and 3 in the control group.

Myocardial Ischemia Induced by Coronary Artery Occlusion
The AR weighed significantly more in the LAD group (0.305 [plus minus] 0.014 g) than in the Cx group (0.206 [plus minus] 0.026 g; P <0.001). In addition, the AR/LV was 40.4% [plus minus] 1.7% in the LAD group and 25.4% [plus minus] 2.9% in the Cx group (P <0.0001). For the variable dura-tion of occlusion of the LAD and the Cx, the AR/LV did not differ significantly. In the LAD group, IF/AR dramatically increased in a time-dependent manner: 4.5% [plus minus] 3.2% after 3 min of occlusion; 9.7% [plus minus] 5.2% after 5 min; 17.2% [plus minus] 3.0% after 7.5 min; 16.8% [plus minus] 2.7% after 10 min; 23.9% [plus minus] 9.5% after 12.5 min; 62.4% [plus minus] 2.9% after 15 min; and 63.4% [plus minus] 2.9% after 20 min (for statistical significance of these results see Fig. 1). The IF/AR in the Cx group increased steadily in a time-dependent manner: 14.3% [plus minus] 2.3% after 5 min of occlusion; 25.9% [plus minus] 2.1% after 10 min; and 40.9% [plus minus] 6.2% after 15 min (for statistical significance, see Fig. 2).

Plasma Nitric Oxide Concentrations
There was no statistically significant relationship between the duration of coronary artery occlusion and the plasma concentration of NO at any of the blood collection time points (Fig. 3). However, significant changes in the plasma concentrations of NO were observed in the time-course study: 26.9 [plus minus] 2.5 M before ischemia, 21.6 [plus minus] 0.9 [mu]M at 10 minutes after reperfusion (P <0.05 compared with pre-ischemia levels), and 48.6 [plus minus] 3.6 [mu]M at 24 hours after reperfusion (P <0.0001 compared with pre-ischemia levels and those at 10 minutes after reperfusion) (Fig. 4).

Discussion

We found no significant correlation between the duration of coronary artery occlusion and the plasma concentration of NO. In the time-course study, the plasma NO had decreased significantly at the beginning of reperfusion but was twice the baseline level 24 hours after reperfusion.

Endothelium-derived NO not only modulates the tone of the underlying vascular smooth muscle but also inhibits several proatherogenic processes, including smooth muscle proliferation and migration, platelet aggregation, oxidation of low-density lipoproteins, monocyte and platelet adhesion, and synthesis of inflammatory cytokines.12 Consequently, interventions aimed at reversing impaired NO synthesis could have important implications for cardiac function.

In the present study, reperfusion affected NO production independent of the duration of coronary occlusion. Many studies have shown that an important feature of ischemia --reperfusion injury is the postischemic impairment of the endothelium, which is partially due to a reduction in NO release.3 --5 Indeed, our study also showed that beginning the reperfusion process decreased the plasma concentration of NO. The decrease in NO production at 10 minutes after reperfusion was likely due to the endothelial dysfunction caused by reperfusion.

A few reports have shown that the release of NO increases because of the inflammatory response associated with the use of CPB in cardiac surgery.13 --15 In those circumstances, the production of such a large amount of NO might be inhibited by treating CPB patients with glucocorticoids, aprotinin, and hemofiltration.13 On the other hand, in human beings it has also been shown that, even during CPB, NO production in the coronary sinus decreases significantly after grafting with an internal thoracic artery.16

L-arginine, the physiologic substrate of NO, reverses low coronary reflow and improves postischemic recovery of cardiac mechanical function.3 Therefore, supplementation with L-arginine may be effective in increasing NO production after coronary surgery ---particularly if OPCAB is used (avoiding CPB).

The increase in the NO concentrations detected 24 hours after reperfusion in our study may have been related to the systemic inflammatory reaction induced by the surgical procedures, or caused by an alternative mechanism that counteracted the reduction in NO concentration. Ferreiro and colleagues17 reported that hypoxia down-regulated endothelial nitric oxide synthase (NOS) activity in the cardiac tissue of cyanotic children; in contrast, inducible NOS activity was up-regulated as a counteraction.

We speculate that, in our study, the plasma NO concentration was independent of the degree of ischemia because of the change in NO release, which may have been diluted in the systemic circulation. One study limitation was that the blood samples were obtained from the femoral vein. Obtaining samples from the coronary sinus would have better reflected the changes in NO release in the heart. However, accessing the coronary sinus in rats is technically difficult, and we considered that the change in NO concentrations in the systemic circulation would indirectly reflect such changes in the heart. Future studies in larger animals may allow collection of blood samples from the coronary sinus so that minor changes in NO concentrations in the heart can be investigated. Another limitation of this study was that the rat heart model involved healthy coronary arteries. Although this limitation would make any extrapolation difficult, we believe that this model could assist in the investigation of several aspects of regional ischemia in OPCAB.

In conclusion, the duration of regional ischemia did not affect the plasma concentration of NO in the systemic circulation. This concentration decreased at the beginning of reperfusion but was twice as high as baseline 24 hours after reperfusion.

Footnotes

Address for reprints: Sharif Al-Ruzzeh, PhD, FRCS, FRCSEd, Leeds General Infirmary, 18 Fielding Way, Leeds LS27 9AB, United Kingdom

E-mail: sharifalruzzeh@hotmail.com

References
1.
Yacoub M. Off-pump coronary bypass surgery: in search of an identity. Circulation 2001;104:1743 --5. [PubMed] [Free Full Text].
2.
Anyanwu AC, Al-Ruzzeh S, George SJ, Patel R, Yacoub MH, Amrani M. Conversion to off-pump coronary bypass without increased morbidity or change in practice. Ann Thorac Surg 2002;73:798 --802. [PubMed].
3.
Amrani M, Chester AH, Jayakumar J, Schyns CJ, Yacoub MH. L-arginine reverses low coronary reflow and enhances postischemic recovery of cardiac mechanical function. Cardiovasc Res 1995;30:200 --4. [PubMed] [Full Text].
4.
Amrani M, Gray CC, Smolenski RT, Goodwin AT, London A, Yacoub MH. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia. Circulation 1997;96(9 Suppl):II-274 --9.
5.
Pernow J, Uriuda Y, Wang QD, Li XS, Nordlander R, Rydeen L. The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J 1994;15:1712 --9. [PubMed].
6.
Spooner TH, Dyrud PE, Monson BK, Dixon GE, Robinson LD. Coronary artery bypass on the beating heart with the Octopus: a North American experience. Ann Thorac Surg 1998;66:1032 --5. [PubMed] [Full Text].
7.
Akins CW, Boucher CA, Pohost GM. Preservation of interventricular septal function in patients having coronary artery bypass grafts without cardiopulmonary bypass. Am Heart J 1984;107:304 --9. [PubMed].
8.
Buffolo E, de Andrade CS, Branco JN, Teles CA, Aguiar LF, Gomes WJ. Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 1996;61:63 --6. [PubMed] [Full Text].
9.
Mills SA. Cerebral injury and cardiac operations. Ann Thorac Surg 1993;56(5 Suppl):S86 --91. [PubMed].
10.
Gundry SR, Romano MA, Shattuck OH, Razzouk AJ, Bailey LL. Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998;115:1273 --8. [PubMed] [Full Text].
11.
Brown PM Jr, Kim VB, Boyer BJ, Lust RM, Chitwood WR Jr, Elbeery JR. Regional left ventricular systolic function in humans during off-pump coronary bypass surgery. Circulation 1999;100(19 Suppl):II125 --7. [PubMed] [Free Full Text].
12.
Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999;31:23 --37. [PubMed] [Full Text].
13.
Hill GE. Cardiopulmonary bypass-induced inflammation: is it important? J Cardiothorac Vasc Anesth 1998;12(2 Suppl 1):21 --5. [PubMed].
14.
Hiramatsu T, Imai Y, Takanashi Y, Hoshino S, Yashima M, Tanaka SA, et al. Time course of endothelin-1 and nitrate an-ion levels after cardiopulmonary bypass in congenital heart defects. Ann Thorac Surg 1997;63:648 --52. [PubMed] [Full Text].
15.
Ruvolo G, Speziale G, Greco E, Tritapepe L, Mollace V, Nistico G, Marino B. Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 1995;9:651 --4. [PubMed].
16.
Tarr FI, Sasvari M, Dudas G, Kroo M, Somogyi A, Tomcsanyi I. Quantitative measurement of endothelium derived nitric oxide production of the internal mammary artery bypass graft during extracorporeal circulation. Eur J Cardiothorac Surg 2001;19:653 --6. [PubMed] [Full Text].
17.
Ferreiro CR, Chagas AC, Carvalho MH, Dantas AP, Jatene MB, Bento De Souza LC, Lemos Da Luz P. Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease: a novel pathophysiological adaptive mechanism. Circulation 2001;103: 2272 --6. [PubMed] [Free Full Text].
Figures and Tables
figure 9FF1
Fig. 1 The IF/AR in the LAD occlusion group.
figure 9FF2
Fig. 2 The IF/AR in the Cx occlusion group.
figure 9FF3
Fig. 3 Correlation between the duration of coronary artery occlusion and the plasma concentration of nitric oxide (NO): A) before ischemia, B) 10 minutes after reperfusion, and C) 24 hours after reperfusion. There was no statistically significant correlation (more ...)
figure 9FF4
Fig. 4 Time course of the plasma concentration of nitric oxide (NO). Samples from the control rats were not included.